There's nothing like a little benign news to start the day, nothing like a voice on the other end of the phone saying, "the pathology on your biopsy came back and everything is benign. We'll see you in one year for your next appointment."

While my dermatologist was freezing the pre-cancerous actinic keratoses lesions on my nose last week, she decided to cut out a suspicious chunk of skin on my hand. It was much worse than the freezing. She gave me a shot and numbed the area and then literally dug a hole into the skin just below the pinkie finger on my right hand. For days now, I've been applying antibiotic ointment, bandaging the wound, and whining about the twinges of pain that shoot through my hand.

My hand is still sore today. But I don't have skin cancer. And that makes the pain a whole lot more tolerable.

There are four pages in the March 2007 Reader's Digest featuring amazing discoveries, devices, tests, and cures. And many of the snippets of information are -- yes -- somehow linked to cancer.

Think about this:

• A new ultrasound technique lets radiologists distinguish between malignant and benign breast lesions. Using elasticity imaging, researchers accurately identified harmless and cancerous lesions in almost all of the 80 cases studied. If results can be reproduced in a large trial, this technique could significantly reduce the number of breast biopsies required.

• Scientists seeking new treatment for diseases can use an online tool developed by researchers at MIT and Harvard. The Connectivity Map matches diseases with compatible drugs, based on the genetic profiles of both. So far, about 160 drugs and compounds are cataloged, and a few new uses for existing drugs have already been suggested. Eventually, all FDA-approved drugs will be included.

• For those who sometimes forget to take their pills, a new device -- that can be preloaded with up to 100 doses of medication -- could one day be implanted in the body and programmed to administer drugs via wireless signals. This device, successful in tests using dogs, was designed to deliver medicines that are less effective when taken orally.

Sometimes it seems cancer's grip is tightening. Other times, in the war against this pesky disease, it seems we are on the verge of something really great.

The National Institutes of Health (NIH) has awarded Techniscan Medical Systems (TMS), a Utah-based company that has developed an ultrasound imaging system known as UltraSound CTTM, a $2.8 million dollar small business grant to go forward with a radiation-free, non-invasive, breast cancer screening device that does not compress the breast during examination.

How does it work? While a woman is lying face down, the breast is suspended in warm water and an ultrasound scanner rotates in a circle, producing detailed 3-D images. According to the company, the diagnostic imaging tool will be able to detect normal, benign and malignant tissues in the breast.

To learn more about the UltraSound CTTM, visit the TMS website.

The ultrasound technique called elasticity imaging might be able to reduce the amount breast biopsies given to patients. It works almost like a regular ultrasound examination of the breast except it is much more sensitive. The technique gauges how much tissue moves when pushed to detect how soft or stiff the mass is in the breast.

The study that was done showed that all 17 of the imaging studies thought to be malignant were found to be malignant after a biopsy was done. It also identified 105 out of the 106 benign lumps in the breast. From this study it suggests that elasticity imaging is 100 percent sensitive and 99 percent specific.

This could turn out be another useful tool used along with mammography and breast MRI's to detect a cancerous lesion in the breast. I, however, will always want a lump biopsied since I know that is the only way to know 100 percent whether it is malignant or benign.

(Thanks to Patti Anastasi for the tip)

The UK's Daily Mail has published an incredible news story featuring a surgical procedure that cuts out tumors so quickly that it allows women to undergo breast surgery to remove breast lumps during their lunch break.

According to an explanation of how this works, in a procedure that lasts at the longest 30 minutes -- using a machine called Soros -- a small incision is made (that heals quickly and leaves no scar); the lump is sliced up into tiny pieces and vacuumed out of the body; and the woman has time left over to presumably have lunch.

This high-tech procedure is currently in clinical trials at the Princess Grace Hospital in London, and is expected to be used in the surgical removal of both benign and malignant tumors up to three centimeters in size. For a detailed step-by-step description, read Breast cancer surgery in your lunch break.